Skip to content

ClearPoint Neuro CLPT Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$9.55M-22.7%-$7.79M-32.2%-$5.89M-0.9%-$5.84M+3.1%-$6.03M-11.9%
$86K-65.5%$249K+277%$66K-83.3%$396K+284%$103K-57.1%
$2.22M+12.0%$1.98M-2.0%$2.02M-10.9%$2.27M+18.9%$1.91M+12.0%
-$7.97M+33.9%-$12.06M-286%-$3.12M-22.3%-$2.55M+58.7%-$6.17M-397%
$645K+1,216%$49K-75.4%$199K+119%$91K-50.3%$183K-30.4%
$284.25K0.0%$284.25K0.0%$284.25K0.0%$284.25K
-$645K-159%$1.09M+647%-$199K-119%-$91K+50.3%-$183K+30.4%
-$1.85M-109%$19.56M$0-100%$31.98M+2,448%-$1.36M-3,781%
-$10.46M-222%$8.57M$29.33M+480%-$7.72M-425%
-$8.61M+28.8%-$12.1M-265%-$3.32M-25.6%-$2.64M+58.4%-$6.36M-322%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does ClearPoint Neuro generate?
ClearPoint Neuro (CLPT) generated -$25.7M in operating cash flow over the trailing twelve months.
What is ClearPoint Neuro's free cash flow?
After $984.0K of capital expenditures, ClearPoint Neuro's free cash flow was -$26.7M over the trailing twelve months, down 127.3% year over year.
Where does ClearPoint Neuro's cash flow data come from?
Every line is extracted from ClearPoint Neuro's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.